Literature DB >> 8195512

Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values.

J Karjalainen1, M Viitasalo, M Mänttäri, V Manninen.   

Abstract

OBJECTIVES: The aim of this study was to establish the relation between QT intervals and a wide range of rest heart rates in men. These data provided the basis of a simple method for adjusting the QT interval for heart rate.
BACKGROUND: Earlier correction equations give conflicting results, especially at low and high heart rates.
METHODS: The QT intervals were measured in 324 electrocardiograms of healthy young men. The sample was weighted for low and high heart rates. A curve relating QT intervals and heart rates from 40 to 120 beats/min was constructed. The QT interval at 60 beats/min was used as the reference value, and an adjusting nomogram for different heart rates was created. The reliabilities of the nomogram and three earlier QT correction equations were tested in the study group and in 396 middle-aged men.
RESULTS: The nomogram method presented (QTNc = QT + correcting number) adjusted the QT interval most accurately over the whole range of heart rates on the basis of smallest mean-squared residual values between measured and predicted QT intervals. The Fridericia formula (QTFc = QT/RR1/3) gave the best correction at low, but failed at high, heart rates. The linear regression equation (QTLc = QT + 0.154[1 - RR], Framingham Study) was reliable at normal, but failed at low and high, heart rates. The Bazett formula (QTc = QT/RR1/2) performed poorest at all heart rates. The relation between QT and RR intervals was determined by three linear regressions expressing the slopes 0.116 for heart rates < 60 beats/min, 0.156 for heart rates from 60 to 100 beats/min and 0.384 for heart rates > 100 beats/min.
CONCLUSIONS: The QT-RR relation over a wide range of heart rates does not permit the use of one simple adjustment equation. A nomogram providing, for every heart rate, the number of milliseconds that the QT interval must be corrected gives excellent adjustment.

Entities:  

Mesh:

Year:  1994        PMID: 8195512     DOI: 10.1016/0735-1097(94)90654-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  56 in total

Review 1.  Assessing the cardiac safety of ebastine. Epilogue.

Authors:  D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

2.  Comparison of formulae for heart rate correction of QT interval in exercise ECGs from healthy children.

Authors:  A Benatar; T Decraene
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

3.  Correction for heart rate is not necessary for QT dispersion in individuals without structural heart disease and patients with ventricular tachycardia.

Authors:  Vassilios P Vassilikos; Labros A Karagounis; Apostolos Psichogios; Themistoclis Maounis; John Iakovou; Antonis S Manolis; Dennis V Cokkinos
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-01       Impact factor: 1.468

4.  More light on QT interval measurement.

Authors:  L Toivonen
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Cardiac effects of chronic oral beta-blockade: lack of agreement between heart rate and QT interval changes.

Authors:  Fabrice Extramiana; Pierre Maison-Blanche; René Tavernier; Luc Jordaens; Antoine Leenhardt; Philippe Coumel
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

6.  QT interval as a cardiac risk factor in a middle aged population.

Authors:  J Karjalainen; A Reunanen; P Ristola; M Viitasalo
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

7.  Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study.

Authors:  Peter A Noseworthy; Aki S Havulinna; Kimmo Porthan; Annukka M Lahtinen; Antti Jula; Pekka J Karhunen; Markus Perola; Lasse Oikarinen; Kimmo K Kontula; Veikko Salomaa; Christopher Newton-Cheh
Journal:  Circ Cardiovasc Genet       Date:  2011-04-21

8.  Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?

Authors:  Emmanuel M Kanoupakis; George E Kochiadakis; Emmanuel G Manios; Nikolaos E Igoumenidis; Hercules E Mavrakis; Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2003-02       Impact factor: 1.900

Review 9.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

10.  Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling study.

Authors:  Barbara Wiśniowska; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-15       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.